Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-010300
Filing Date
2019-08-07
Accepted
2019-08-07 16:44:25
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgmo-20190630x10q.htm   iXBRL 10-Q 1827792
2 EXHIBIT 31.1 sgmo-20190630xex311.htm EX-31.1 13267
3 EXHIBIT 31.2 sgmo-20190630xex312.htm EX-31.2 13389
4 EXHIBIT 32.1 sgmo-20190630xex321.htm EX-32.1 10334
  Complete submission text file 0001628280-19-010300.txt   7710004

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20190630.xsd EX-101.SCH 50589
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20190630_cal.xml EX-101.CAL 84240
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20190630_def.xml EX-101.DEF 243330
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20190630_lab.xml EX-101.LAB 645272
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20190630_pre.xml EX-101.PRE 379935
10 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20190630x10q_htm.xml XML 1375043
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 191006113
SIC: 2836 Biological Products, (No Diagnostic Substances)